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The mouse IgG1 monoclonal antibody (mAb) K21 recognizes a 230-kD molecule (K21-Ag) on
Hassall’s corpuscles in the human thymus. This mAb also stains cultured thymic epithelial cells
as well as other epithelial cell lines, revealing a predominant intracellular localization. Further
analysis with mAb K21 on other lymphoid tissues showed that it also stains cells within the
germinal centers of human tonsils, both lymphoid (B) cells and some with the appearance of
follicular dendritic cells. Double immunostaining of tonsil sections shows that K21-Ag is not
expressed by’T cells, whereas staining with anti-CD22 and -CD23 mAb revealed some double-
positive cells. A subpopulation of the lymphoid cells express the K21-Ag much more strongly.
This K21++/CD23++ subpopulation of cells is localized in the apical light zone of germinal
centers, suggesting that K21-Ag may be an important marker for the selected centrocytes within
germinal centers and may play a role in B-cell selection and/or development of B-cell memory.
Flow cytometric analysis showed that K21-Ag is expressed on the surface of a very low
percentage of thymocytes, tonsillar lymphocytes, and peripheral blood mononuclear cells.
Analysis of purified/separated tonsillar T and B lymphocytes showed that T cells do not express
the K21-Ag; in contrast, B cells express low levels of the K21-Ag, and this together with CD23
is upregulated after mitogenic stimulation. Our data therefore raise the possibility that the K2 l-
Ag may play a role in B-lymphocyte activation/selection.
Keywords: Follicular dendritic cell, germinal center, lymphocyte development, thymic epithelium, thymic
microenvironment, thymus
INTRODUCTION
Monoclonal antibodies (mAbs) have provided valua-
ble tools with which to study anatomical and
Corresponding author.
functional niches within the thymic microenviron-
ment (Boyd et al., 1993; Ritter and Boyd, 1993).
Several of these mAbs, raised in our laboratory to
both human and mouse thymic epithelial cells, have
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been shown to detect antigens shared by thymic
epithelium and leukocytes (DeMaagd et al., 1985;
Kampinga et al., 1989; Imami et al., 1992). One such
molecule, gp200-MR6, which is expressed by human
thymic cortical epithelium, is thought to be func-
tionally associated with the human interleukin-4
receptor (IL-4R; Larch6 et al., 1988; Imami et al.,
1994; A1-Tubuly et al., 1996). These data, together
with our observations that the phenotype of thymic
epithelium can be modulated by IL-4 suggested that
lymphocyte-derived IL-4 might play a role in main-
taining the thymic microenvironment (Freysd6ttir and
Ritter, 1998). In order to further analyze IL-4R
structure and function on thymic epithelium, we
attempted to generate mAbs to the human IL-4R
following immunization of (CBA/BALB/c)F1 mice
with keyhole limpet hemocyanin (KLH)-coupled syn-
thetic peptides based on the published cDNA sequence
of the 140-kD chain of the IL-4R (CD124; Galizzi et
al., 1990). After fusion and subsequent cloning, several
mAbs were identified that were reactive with thymic
epithelial cells and lymphocytes, although their dis-
tribution did not resemble that of the IL-4R, as
revealed by fluoresceinated IL-4 (Mat et al., 1991).
We have now analyzed these mAbs further and show
that one of them, mAb K21, which labels thymic
Hassall’s corpuscles and surrounding patches of medul-
lary epithelium, also recognizes tonsillar epithelium and
germinal center cellsmboth lymphoid cells and some
with the appearance of follicular dendritic cells. Further
studies with two-color immunohistochemistry, flow
cytometry, Western blotting, and mitogen activation
have been undertaken to determine the nature of the
K21-Ag, and the lineage and functional status of the
cells that express it. These studies should help to
elucidate the role of the thymic epithelium and its
similarity with other lymphoid microenvironments.
RESULTS
Distribution, Expression, and Biochemical
Analysis of the K21-Ag
MAb K21 was raised against a cocktail of KLH-
coupled synthetic peptides of the IL-4R (Galizzi et al.,
1990). It was screened by ELISA using individual
peptides (coupled to BSA) and showed strong reac-
tivity with WSXWS, but was not reactive with other
peptides. As this motif is a functional part of all
cytokine receptors within the haematopoietin cyto-
kine receptor superfamily, including IL-2R/3
(CD122), IL-4R (CD124), IL-7R (CD127), and the
common y chain (yc), we pursued with analysis of
this mAb (Bazan, 1990; Miyajima et al., 1992;
Sugamura et al., 1996). Additionally, the mAb K21
was screened on human thymus and was shown to
strongly label some Hassall’s corpuscles and
occasionally the associated medullary epithelium
(cluster of thymic epithelial staining; CTES group V).
The K21 Hassall’s corpuscles are generally those
that are medium to large in size (Figure 1). Isotyping
showed it to be an IgG1 mAb.
Western blotting analysis, using freshly prepared
lysates from frozen tonsillar tissue, revealed that K2l-
Ag comprised one band with an apparent molecular
weight of approximately 230 kD (Figure 2). Western
blotting carried out under reducing conditions, using
either 2-Mercaptoethanol (2-ME) or Dithiothreitol
(DTT), destroyed the epitope recognized by mAb
K21. Flow cytometric analysis of thymic epithelial
cells from primary cultures (Figure 3) shows that
most of K21-Ag is expressed internally and that this
expression increases over 5 to 8 days in culture
medium. Neither IFNy nor IL-4 had any effect on the
expression of this molecule (data not shown). In
addition, indirect immunofluorescence staining and
flow cytometric analysis of the human epithelial cell
line (HT29) showed that this molecule is also
expressed internally in other epithelial cell lineages,
whereas surface molecules are also present on a small
percentage of cells (2-5%; Figure 4). Indirect immu-
noperoxidase staining of these cells in culture con-
firmed the predominant intracellular localization of
the K21-Ag (Figure 5).
When tested on other lymphoid tissue, mAb K21
revealed staining of human tonsils. Single immuno-
peroxidase staining of human tonsil sections showed
that this mAb stains the stratified squamous tonsillar
epithelium and cell populations within the germinal
centers of the follicles where both the B cells
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FIGURE 2 Western blotting analysis. Frozen tonsil tissue lysates
were subjected to SDS-10%PAGE and immunoblotting. Negative
control (lane 1); gp200-MR6 (200 kD, lane 2); K21-Ag (230 kD,
lane 3); CD4 (negative, lane 4); CD23 (45 kD, lane 5); and CD45
(220 kD, lane 6). Under nonreducing conditions, the K21-Ag has an
apparent molecular weight of 230 kD.
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FIGURE 3 Flow cytometric analysis of either surface or internal
and/or surface expression of K21-Ag on cultured human thymic
epithelial cells. Cells were isolated and cultured for 0-8 days in
supplemented culture medium only. Results are expressed as mean
percentage of stained cells _+ standard deviation of three experi-
ments.
lymphocytes showed that T cells do not express the
K21-Ag, whereas --14% of B cells are K21-Ag-
positive (Table I). Flow cytometric analysis of
separated tonsillar B lymphocytes after 24-hr mitogen
stimulation (lipopolysaccharide, LPS) raised the
percentage of K21-Ag-positive cells from 14% to
62% (total percentage of B cells was 80%). Therefore,
it appears that K21-Ag expression is upregulated
upon B-cell activation.
DISCUSSION
The aim of this study was to raise mAbs to the IL-4R
as part of the project to explore the role of cytokine/
cytokine receptor interactions between the thymic
stromal microenvironment and the maturing T
lymphocytes, since it has been shown that interactions
such as those occurring between IL-4/IL-4R and IL-
7/IL-7R are important in development of both thymo-
cytes and the thymic epithelial component (Ritter and
Boyd, 1993; Peschon et al., 1994; Zlotnik and Moore,
1995; Freysd6ttir and Ritter, 1998). Although we
immunized with known peptides of the IL-4R, after
the fusion, selection, and subsequent cloning, none of
the mAbs showed recognition of the IL-4R. However,
some of them showed reactivity with thymocytes and/
or the thymic epithelial cells. K21, which recognized
Hassall’s corpuscles and associated medullary epi-
thelium, was selected for further study.
It is not clear why the methodology used failed to
generate mAbs to the IL-4R. Mice were immunized
with a mixture of five different synthetic peptides
based on the sequence of the human IL-4R. Peptides
were selected for their potential immunogenicity and
exposure on the surface of the native molecule, and
were coupled to KLH to provide a highly immuno-
genic carrier. The failure to generate anti-IL-4R mAb
may result from close conservation of sequence
between mouse and man; alternatively, the three-
dimensional structure of the peptide-carrier com-
plexes may differ from that of the equivalent
sequence in the native molecule.
The generation of non-IL-4R mAb was not unex-
pected since similar findings have been observed
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previously in our laboratory as well as by other
investigators (Sharif et al., 1990; Freysd6ttir et al.,
manuscript in preparation). One possibility is that we
have selected auto-antibody producing cells that
cross-react between species. Thus, human anti-
GlcNAc antibodies cross-react with cytokeratin from
human skin (Shikhman and Cunningham, 1994),
although the 230-kD K21-Ag is too large to be a
keratin (Laster et al., 1986). Moreover, the mAb
TOTO-1 generated from a patient with systemic lupus
erythematosus (SLE) has been shown to be reactive
with Hassall’s corpuscles, indicating the presence of
autoreactive antibodies with specificity for thymic
epithelium (Numasaki et al., 1995).
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FIGURE 4 K21-Ag expression on HT29 human epithelial cell line analyzed by flow cytometry: (a) surface, and (b) internal and/or surface
expression levels. Isotype-matched control mAb (OKT3) was used as a negative control (<2.0% in both cases).
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TABLE Flow Cytometric Analysis Using mAb K21 on
Separated Tonsillar T Cells (E-Rosetted) and B Cells (Nylon Wool
Bound)"
% stained cells
E-rosetted Nylon wool bound
(T) cells (B) cells
CD20 9 91
CD19 8 96
CD3 86 5
CD7 85 4
CD14 3
CD68 3
K21-Ag 3 14
Negative control 2 3
aExperiments were carried out three times and a representative
experiment is shown.
HT29 cells in culture confirmed the predominant
intracellular localization of this antigen. Whether the
K21-Ag functions intracellularly or whether the
intracellular molecules provide a pool from which
molecules can rapidly be recruited to the cell surface
is not known.
MAb K21 also stains tonsillar epithelial cells. This
fits well with the data of Perry and Slipka (1993), who
studied the formation of the tonsillar corpuscles
(epithelial structures found in the vicinity of the
crypts) and showed that these structures closely
resemble thymic Hassall’s corpuscles (a phenomenon
explained by endodermal embryological origin of the
primordia of both organs; Perry and Slipka, 1993).
K21 also labels patches of cells that resemble
follicular dendritic cells in the tonsillar germinal
centers, and is expressed at low levels on tonsillar B
cells (identified by their location and dual staining
with B-lineage markers). K21-positive cells in the T-
cell area are CD5-negative, thus indicating that T cells
do not bear this antigen and that the scattered positive
cells are likely to be B cells. The presence of K21-Ag
in/on follicular dendritic cells indicates that for both
germinal centers and thymus (Hassall’s corpuscles),
the K21-Ag seems to be present on elements of the
microenvironment where lymphocyte selection and
apoptosis occur (Gray, 1993; Douek and Altmann,
manuscript in preparation), suggesting a role for K21-
Ag in the interaction of the selected lymphocytes with
their microenvironment.
Further flow cytometric and functional analysis
showed that a subpopulation of B cells is K21-Ag-
positive and that this is expanded on activation. Since
activation is associated with the events of lymphocyte
selection, this raises the possibility that K21-Ag in the
tonsil is present on both the selecting microenviron-
ment and on the selected cells, paralleling data
obtained with CD23 (Liu et al., 1991; MacLennan et
al., 1992; Gray, 1993; MacLennan, 1994). A similar
situation may exist in the thymus since B lympho-
cytes have been shown to be present in the normal
human thymic medulla; these are concentrated around
Hassall’s corpuscles and often have rosettes of
thymocytes around them (Spencer et al., 1992).
Various disorders, including infections, therapeutic
treatments, irradiation, and immune deficiencies, are
associated with thymic involution and loss of medul-
lary epithelium, including/excluding loss of Hassall’s
corpuscles. In HIV-related disease, in the pediatric
population of of the most common disorders is thymic
dysinvolution with loss of Hassall’s corpuscles (Mis-
halani et al., 1995). In contrast, in adults with early
stage of AIDS, the adipose-involuted thymus shows
persistence of many Hassall’s corpuscles together
with lymphoid follicular hyperplasia (Prevot et al.,
1992). These differences might reflect differences in
the lymphocyte populations involved in the two
disease situations since maintenance of medullary
epithelium is known to be influenced by the surround-
ing thymocytes (Ritter and Boyd, 1993). Thus, loss of
mature medullary thymocytes either due to cyclo-
sporin A treatment or in T-cell-deficient mice leads to
loss of the thymic medullary epithelium (including
Hassall’s corpuscles) (Kanariou et al., 1989; van
Ewijk, 1991; Palmer et al., 1993).
The mAb K21 therefore recognizes a novel 230-kD
molecule expressed by microenvironmental cells of
thymus and tonsil that play an important role in
lymphocyte selection. Investigations to define more
fully the structure and function of this molecule and to
determine its role, if any, in lymphocyte-selection
events are currently in progress.
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MATERIALS AND METHODS
Source of Tissues, Cells, and Cell Lines
Human thymus and tonsil tissue and tissue
sections
Thymus samples were obtained from children under-
going cardiac surgery (Great Ormond Street Hospital
for Sick Children, London) and freshly excised tonsils
from children that had undergone tonsillectomy (ENT
Clinic, St. Mary’s Hospital, London). Six-micron
tissue sections cut from liquid nitrogen frozen blocks
were air dried for 24 hr, fixed in acetone (BDH, Poole,
UK) for 10 min, and either used immediately or stored
at -20C until used.
Thymocytes, tonsillar lymphocytes, and PBMC
Fresh thymus or tonsil tissue was thoroughly teased to
release the lymphocytes, samples were allowed to
sediment for 10 min, and the lymphocyte-containing
supernatant was collected and washed three times in
HEPES (20 mM) buffered RPMI 1640 (ICN Flow,
Thame, UK). The recovered cell suspension was then
centrifuged over Ficoll-Hypaque (688 g, 20 min;
Pharmacia Biotech, St. Alban’s, UK). Mononuclear
cells were collected from the interface and washed
twice in HEPES/RPMI. Medium containing 50/xg/ml
gentamycin was used for tonsils. Peripheral blood
from healthy donors was collected into heparinized
30-ml universal containers (Bibby Sterilin, Stone,
UK) containing 100 U of preservative-free heparin
(Leo Laboratories, Princes Risborough, UK). PBMC
were isolated by density-gradient centrifugation using
Ficoll-Hypaque as described before.
Fresh stromal cells and human thymic epithelial
cell cultures
The remaining thymic stroma (sedimenting frag-
ments) were processed by digestion in collagenase
and epithelial cells were further isolated and cultured
as described by Freysd6ttir and Ritter (1998). Cells
were cultured for 8 days in either medium only, IFNy
(100 U/ml) or IL-4 (25 U/ml) (both Genzyme, West
Malling, UK), harvested on days 0, 5, and 8, and
analyzed by flow cytometry as described in what
follows.
Human epithelial cell line, HT29
This is a well-differentiated colonic carcinoma cell
line (American Type Culture Collection, ATCC,
Rockville, MD; Fough and Trempe, 1975). Cells were
cultured in RPMI 1640 supplemented with 10% fetal
calf serum (FCS), L-glutamine (2 mM), sodium
bicarbonate (2 g/l), penicillin (100 IU/ml), and
streptomycin (100 /xg/ml) (all ICN Flow). HT29
epithelial cells were grown in glass slide flasks (Nunc,
Roskilde, Denmark) until confluent, washed exten-
sively in phosphate-buffered saline (PBS), fixed in
acetone for 10 min, and the immunoperoxidase
staining was performed as described in what fol-
lows.
Source of Antibodies
K21 is an IgG1 murine mAb, reactive with Hassall’s
corpuscles of the human thymic epithelium, raised
following i.p. immunization of (CBA/BALB/c)F1
mice with synthetic peptides (MKVLQXPTCVSDY,
KPSXHVKPR, SXNDPADFRI, WSXWS, and
FVSVGPTYMRVS coupled to KLH), based on the
published cDNA sequence of the 140-kD chain of the
IL-4R (Galizzi et al., 1990), and fusion of immune
spleen cells with NSO myeloma cells (Kearney et al.,
1979). Immunization, fusion, HAT selection, and
cloning were carried out as described previously
(DeMaagd et al., 1985; Ladyman and Ritter, 1995).
Screening was carried out by ELISA using immobil-
ized individual peptides and by indirect immunoper-
oxidase staining of frozen tissue sections of human
thymus.
MAb K21 was used as tissue-culture supernatant
and its isotype determined using an isotyping kit
(Serotec, Oxford, UK). Mouse anti-human CD3,
CD4, CD5, CD7, CD14, CD19, CD20, CD22, CD23,
CD45, and CD68 were also used as primary anti-
bodies (all Dako, High Wycombe, UK). MAb MR6
(recognizes the gp200-MR6 molecule) is an IgG1
murine mAb and was used as tissue-culture super-
natant (DeMaagd et al., 1985; Larch6 et al., 1988;
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Imami et al., 1994). Second-layer reagents were
horseradish peroxidase (HRP)-conjugated rabbit anti-
mouse Ig, alkaline phosphatase (AP)-conjugated rab-
bit anti-mouse Ig, and fluorescein isothiocyanate
(FITC)-conjugated rabbit anti-mouse Ig (all Dako).
All antibodies were titrated before use.
lmmunohistochemistry
Single indirect immunohistochemical staining of
human thymus and tonsil sections
Tissue sections were incubated with primary antibody
for 1 hr at room temperature, washed in PBS, and then
incubated hr further with either FITC- or HRP-
conjugated rabbit anti-mouse Ig at 1/20 in PBS
containing 5% normal human serum (NHS). For
immunofluorescence, sections were mounted in a AF2
mountant (Citifluor, Canterbury, UK). For enzyme
staining, sections were developed for 10 min using 6
mg diaminobenzidine (DAB; Sigma, Poole, UK) and
5 /xl 30% H202 (Sigma) per 10 ml PBS, counter-
stained with hematoxylin, and mounted in Kaiser’s
gelatin-based mountant. No staining was seen when
the primary antibody was either omitted or replaced
by an irrelevant isotype-matched control.
Double immunoenzyme staining of human tonsil
sections
Sections were incubated for 45 rain with one set of
primary antibodies, followed by HRP-conjugated
secondary antibody (45 min), and developed as
described before, and then incubated for an additional
45 min with the second set of primary and AP-
conjugated rabbit anti-mouse Ig (45 min). AP labeling
was developed over 20 rain using 0.1% fast blue BB
salt with 0.02% napthol-AS-MX phosphate, 0.2%
levamisole (all Sigma), and 2% dimethyl formamide
(BDH). All incubations were carried out at room
temperature and all washes were with Tris-buffered
saline (TBS), pH 7.6. No double staining was seen
when either the first or the second primary mAb was
omitted or replaced by the isotype-matched control.
Biochemical Analysis of K21-Ag
For Western blotting analysis, 30 sections of frozen
human tonsil tissue were cut on a cryostat at a
thickness of 10/xm and lysed for 10 min in ml of
ice-cold lysis buffer (10 mM Tris/HC1, pH 7.4,
containing 150 mM NaC1, 0.5% NP-40, and mM
PMSF; all Sigma) and then centrifuged in a 1.5-ml
plastic tube (Eppendorf, Hamburg) at 13,000 g for 4
min at 4C. The cell-free supernatant was mixed
with an equal volume of either reducing (10% 2-ME
or 300 mM DTT) or nonreducing double-strength
Laemmli sample buffer, subjected to SDS-10%PAGE
(Laemmli, 1970) and followed by electrophoretic
transfer (300 mA for to 1.5 hr; Towbin et al., 1979)
onto nylon membranes (Milipore, Bedford, MA).
Unoccupied charged sites on the membrane were
blocked by immersion in 2.5% skimmed milk powder
(Cadbury, Stafford, UK) in PBS for 3 to 24 hr.
Membranes were cut into vertical strips that were
incubated for 2 hr with either mAb K21 (1/3), anti-
CD23, anti-CD45, anti-CD4 (all 1/10), mAb MR6
(1/3), or isotype-matched negative control mAb
(H17E2; Travers and Bodmer, 1984) at --10/xg/ml in
0.5% skimmed milk powder in PBS (this buffer was
used for subsequent Ab dilutions and washing of
strips). Following washing for 15 min in three
changes of washing buffer, strips were incubated for 1
hr in a 1/100 dilution of HRP-conjugated rabbit anti-
mouse Ig. Strips were then washed and peroxidase
activity developed by incubation in 0.6 mg/ml DAB
in 10 ml PBS, containing 5/xl H202.
Indirect Immunofluorescence and Flow
Cytometric Analysis" Surface and Internal
Staining
For analysis by flow cytometry, 1 106 cells of each
group were incubated with 100/zl (neat supernatant
or 1/10 dilution of Dako mAbs) of the indicated mAb
for hr on ice in polystyrene round-bottomed tubes
(Falcon, Becton-Dickinson, Lincoln Park, NJ)
(Larch6 et al., 1988). After washing twice in medium,
the cells were incubated for an additional hr on ice
with 100 /xl of a 1/20 dilution of FITC-conjugated
rabbit anti-mouse Ig. After three additional washes,
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stained cells were analyzed using an Epics XL-MCL,
Flow cytofluorimeter with log amplifier (Coulter,
USA). For internal staining, cells were treated with
0.1% saponin in PBS, and this buffer was used in all
subsequent washes.
Tonsillar Cell Separation and Mitogen
Stimulation
T and B cells were separated by E-rosetting and nylon
wool, respectively. For E-rosetting, cells were pre-
pared by mixing tonsillar mononuclear cells with
sheep red blood cells (SRBC; TCS, Buckingham, UK;
modified from Callard et al., 1987). For nylon wool
separation, tonsillar mononuclear cells were resus-
pended in 2 ml of RPMI medium, and loaded on a
prewetted nylon wool (Biotest, Dreieich, Germany)
column (0.2 g/2 ml column). The columns were then
sealed and incubated at 37C for 30 min, T cells were
eluted by washing the columns twice with 10 ml
warm (37C) medium, while B cells were collected by
applying 10 ml of ice-cold medium and agitating the
wool vigorously. A sample of each of these cell
preparations was stained by indirect immunofluores-
cence using both pan-B- and pan-T-cell markers
(CD20, CD19, CD22 and CD3, CD5, CD7, respec-
tively) to gauge their purity (using flow cytometry as
described before). Tonsillar E-rosetted cells were
routinely 80-90% (CD3/) T cells, <10% (CD20+) B
cells. Tonsillar nylon-wool-bound cells were
routinely 90-95% (CD20+) B cells, <5% (CD3+) T
cells. In all experiments, 1% to 3% were monocytes
(CD14/, CD68/). Separated B cells were cultured in
both the presence and absence of lipopolysaccharides
(LPS; 10 /zg/ml; Sigma) for 24 hr, harvested, and
analyzed by flow cytometry as described before.
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